가족성 전립선암 환자군에서 종양 성장 억제 유전자 단백질(P53) 변이가 1.6%로 비가족성 환자군보다 더 높았다.
In the prostate cancer patient group with family history, the tumor growth inhibiting gene protein (P53) mutation was 1.6%, higher than that of patients without family history.